Wang H - Search Results

1

Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION-8 randomized controlled trial.

Frías JP, Hardy E, Ahmed A, Öhman P, Jabbour S, Wang H, Guja C. Frías JP, et al. Among authors: wang h. Diabetes Obes Metab. 2018 Jun;20(6):1520-1525. doi: 10.1111/dom.13296. Epub 2018 Apr 19. Diabetes Obes Metab. 2018. PMID: 29573139 Free PMC article. Clinical Trial.

2

Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes.

Marso SP, Hardy E, Han J, Wang H, Chilton RJ. Marso SP, et al. Among authors: wang h. Diabetes Ther. 2018 Apr;9(2):551-564. doi: 10.1007/s13300-018-0370-z. Epub 2018 Feb 3. Diabetes Ther. 2018. PMID: 29397532 Free PMC article.

3

Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study.

Guja C, Frías JP, Somogyi A, Jabbour S, Wang H, Hardy E, Rosenstock J. Guja C, et al. Among authors: wang h. Diabetes Obes Metab. 2018 Jul;20(7):1602-1614. doi: 10.1111/dom.13266. Epub 2018 Mar 25. Diabetes Obes Metab. 2018. PMID: 29473704 Free PMC article. Clinical Trial.

4

Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial.

Jabbour SA, Frías JP, Hardy E, Ahmed A, Wang H, Öhman P, Guja C. Jabbour SA, et al. Among authors: wang h. Diabetes Care. 2018 Oct;41(10):2136-2146. doi: 10.2337/dc18-0680. Epub 2018 Aug 6. Diabetes Care. 2018. PMID: 30082326 Free PMC article. Clinical Trial.

5

Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials.

Vetter ML, Johnsson K, Hardy E, Wang H, Iqbal N. Vetter ML, et al. Among authors: wang h. Diabetes Ther. 2019 Aug;10(4):1249-1270. doi: 10.1007/s13300-019-0627-1. Epub 2019 May 10. Diabetes Ther. 2019. PMID: 31077072 Free PMC article.

6

Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 study.

Wysham CH, Rosenstock J, Vetter ML, Wang H, Hardy E, Iqbal N. Wysham CH, et al. Among authors: wang h. BMJ Open Diabetes Res Care. 2020 Oct;8(1):e000773. doi: 10.1136/bmjdrc-2019-000773. BMJ Open Diabetes Res Care. 2020. PMID: 33037036 Free PMC article. Clinical Trial.

7

Effect of expanded dulaglutide weekly doses (3.0 mg and 4.5 mg) on cardiovascular disease risk factors in participants with type 2 diabetes at increased cardiovascular disease risk: a post hoc analysis of the AWARD-11 study.

Cox DA, Wang H, Nicolay C, Bethel MA. Cox DA, et al. Among authors: wang h. Diabetes Obes Metab. 2022 Sep;24(9):1770-1778. doi: 10.1111/dom.14762. Epub 2022 May 29. Diabetes Obes Metab. 2022. PMID: 35546790 Free PMC article.

8

Tirzepatide in Hispanic/Latino Patients With Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program.

Frías JP, Galindo RJ, Wang H, Malik RE, Chivukula KK, Maldonado JM. Frías JP, et al. Among authors: wang h. J Clin Endocrinol Metab. 2024 Jan 18;109(2):557-568. doi: 10.1210/clinem/dgad495. J Clin Endocrinol Metab. 2024. PMID: 37602701 Free PMC article.

9

Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2).

Frias JP, De Block C, Brown K, Wang H, Thomas MK, Zeytinoglu M, Maldonado JM. Frias JP, et al. Among authors: wang h. J Clin Endocrinol Metab. 2024 Jan 22:dgae038. doi: 10.1210/clinem/dgae038. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38252888

10

Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trial.

Hankosky ER, Wang H, Neff LM, Kan H, Wang F, Ahmad NN, Stefanski A, Garvey WT. Hankosky ER, et al. Among authors: wang h, wang f. Diabetes Obes Metab. 2023 Dec;25(12):3748-3756. doi: 10.1111/dom.15269. Epub 2023 Sep 12. Diabetes Obes Metab. 2023. PMID: 37700443 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141,566 results

Search Page